Valion Bio director Jensen Thomas becomes reporting insider

New Valion Bio director Jensen Thomas filed an initial Form 3 showing no reported holdings or transactions.

Rhea-AI Filing Summary

Valion Bio, Inc. (VBIO) reported that Jensen Thomas has become a reporting person as a director through an initial ownership filing. The Form 3 does not list any equity holdings or report any transactions in Valion Bio securities for Jensen Thomas at this time, and it references an attached Power of Attorney.

Key Terms

Form 3, reporting person, Power of Attorney

3 terms

Form 3 regulatory

"reported that Jensen Thomas has become a reporting person as a director through an initial ownership filing"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reporting person regulatory

"Jensen Thomas has become a reporting person as a director"

Power of Attorney regulatory

"Exhibit 24.1 - Power of Attorney"

A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 3 filing for VBIO disclose about Jensen Thomas?

The Form 3 identifies Jensen Thomas as a director of Valion Bio, Inc. and a reporting person, but it does not list any equity holdings or report any transactions in the company’s securities as of the filing.

Does the VBIO Form 3 show any stock purchases or sales by Jensen Thomas?

No. The Form 3 for Valion Bio, Inc. reports no transactions, with zero shares bought, sold, acquired, or disposed and no derivative transactions disclosed for Jensen Thomas.

What role does Jensen Thomas have at Valion Bio, Inc. (VBIO)?

The filing shows that Jensen Thomas is a director of Valion Bio, Inc. and is therefore required to report ownership and transactions in the company’s securities as an insider under SEC rules.

Is there any Rule 10b5-1 trading plan disclosed in the VBIO Form 3?

No. The document-level Rule 10b5-1 checkbox is not marked, and there are no footnotes or transaction entries indicating that any trades were made under a Rule 10b5-1 trading plan.

What is the significance of the Power of Attorney mentioned in the VBIO Form 3?

The Form 3 notes “Exhibit 24.1 - Power of Attorney,” indicating that Jensen Thomas has authorized another person to sign or submit SEC forms on his behalf, a common administrative arrangement for insider reporting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/17/2026 - 04:31 PM Accepted by SEC EDGAR 09/17/2026 - 04:30 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Jensen Thomas

(Last) (First) (Middle)

1305 E. HOUSTON STREET

BUILDING 1, SUITE 311

(Street)

SAN ANTONIO TEXAS 78205

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
08/27/2026

3. Issuer Name and Ticker or Trading Symbol
Valion Bio, Inc. [ VBIO ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24.1 - Power of Attorney

No securities are beneficially owned.

	/s/ Thomas Jensen	09/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)